CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Recommended from our members
A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis
Author
Friedlaender Mitchell
Levofloxacin Bacterial Conjunctivitis Active Control Study Group
+4 more
Lichtenstein Steven J
Mcculley James
Moran C. Thomas
Schwab Ivan R
Publication venue
Elsevier
Publication date
01/01/2003
Field of study
No full text
University of Miami: Scholarship Miami
Ophthalmika
Author
ADAPT Study Investigator Group
AGIS Investigators
+77 more
AR-12286 Phase 2A Study Group
C Costagliola
C Costagliola
CA Webers
CATT Research Group
CIGTS Optic Disc Study Group
CIGTS Study Group
CM Perry
Collaborative Initial Glaucoma Treatment Study
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group
DB Granet
DS Lai
E Mantadakis
E Ravinet
EM Messmer
F Giardini
F Grehn
F Holz
H Uusitalo
HA Everitt
HA Quigley
HV Danesh-Meyer
I Goldberg
JB Gunther
JR Nordlund
JT Whitson
JV Greiner
L Bielory
L Bielory
Levofloxacin Bacterial Conjunctivitis Active Control Study Group
Levofloxacin Bacterial Conjunctivitis Dosage Study Group
Levofloxacin Bacterial Conjunctivitis Place-controlled Study Group
LJ Katz
Low-Pressure Glaucoma Study Group
M Gharbiya
M Göbbels
M Srinivasan
M Wand
M Wright
MA Kass
MANTA Research Group
Martinez B Orden
MC Grieshaber
MJ Koss
ML Subramanian
MR Chalita
N Pfeiffer
N Yildirim
Ocular Hypertension Treatment Study Group
P Biswas
P Rose
PG Watson
PJ Rosenfeld
PY Robert
R Schalnus
RA Schachar
RM Jansen
RN Weinreb
RP Rietveld
RS Cvetkovic
S Hanioglu-Kargi
S Noble
SJ Isenberg
SJ Sorensen
SL Everett
SS Lynch
The IVAN Study Investigators Writing Committee
the XLT Study Group
TP O'Brien
Travatan Adjunctive Treatment Study) group
TS Dietlein
U Herkel
W Behrens-Baumann
W Haas
WB Jackson
WG Hodge
Y Shiuey
Publication venue
'Springer Science and Business Media LLC'
Publication date
01/01/2013
Field of study
No full text
Crossref